吸入器・ネブライザー市場：製品、適応症、流通形態別-2025-2030年の世界予測

吸入器・ネブライザー市場は、2023年に93億米ドルと評価され、2024年には114億5,000万米ドルに達すると予測され、CAGR 22.55％で成長し、2030年には386億3,000万米ドルに達すると予測されています。

吸入器・ネブライザー市場の範囲には、喘息、慢性閉塞性肺疾患（COPD）、その他の肺疾患などの呼吸器疾患の管理に不可欠な、肺に直接薬剤を供給するように設計された機器が含まれます。これらのデバイスの必要性は、呼吸器疾患の有病率の増加と効率的なドラッグデリバリーメカニズムの需要から生じています。応用分野には、病院、診療所、在宅介護環境などがあり、エンドユーザーは小児から老人まで幅広いです。市場の成長は、技術の進歩、呼吸器疾患に対する意識の高まり、都市汚染による生活習慣に関連した呼吸器疾患の発生率の上昇などの要因に影響されます。成長機会としては、デジタルヘルス追跡を統合したスマート吸入器技術の革新、ヘルスケアインフラの改善が進む新興国市場でのプレゼンス拡大などが挙げられます。

しかし、厳しい規制環境、先端機器に関連する高コスト、後発地域における認知度の低さなどの課題が、成長を阻害する可能性があります。また、治療効果に影響を及ぼす可能性のある機器の不整合や手技のばらつきからも限界が生じる。これらの障害を克服するため、企業は軽量で携帯可能なネブライザーや、精度が向上し患者に優しいインターフェースを備えたコスト効率の高い吸入器の開発などの分野における技術革新に注力することができます。新たな調査手段としては、患者のアドヒアランスをモニターしてフィードバックを提供するスマート吸入器によって促進される個別化医療アプローチがあります。市場プレイヤーは、これらの考察を活用して製品の差別化を強化し、競争力を獲得することができます。戦略的な推奨事項としては、多様な患者のニーズに合わせた適応技術を生み出すための研究開発への投資や、包括的なサービス提供のためのヘルスケアプロバイダーとのパートナーシップの確立などが挙げられます。市場はダイナミックで競争が激しく、従来のソリューションと新しいソリューションに対する需要が同時に高まっており、幅広い呼吸器疾患に対応するユーザーフレンドリーで効率的な設計が重視されています。したがって、吸入器・ネブライザー市場の可能性を最大限に引き出すには、技術的進歩と消費者の嗜好に合わせた製品開拓が鍵となります。

市場力学：急速に進化する吸入器・ネブライザー市場の主要市場インサイトを公開

吸入器・ネブライザー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の呼吸器疾患の有病率の増加
  • ネブライザーとデジタル改良製品の採用増加
  • スマート吸入器メーカーとソフトウェア企業間のデジタルヘルスパートナーシップ
• 市場抑制要因
  • スマート吸入器の開発に伴う限られた入手可能性と高いコスト
• 市場機会
  • スマート吸入器デバイスとシステムの技術的進歩
  • 市場プレイヤーによる投資と研究開発の拡大
• 市場の課題
  • 吸入器・ネブライザーに関連する実用上の問題点

ポーターの5つの力：吸入器・ネブライザー市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、吸入器・ネブライザー市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：吸入器・ネブライザー市場における外部からの影響の把握

外部マクロ環境要因は、吸入器・ネブライザー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析吸入器・ネブライザー市場における競合情勢の把握

吸入器・ネブライザー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス吸入器・ネブライザー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、吸入器・ネブライザー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 呼吸器疾患の世界の増加
    • ネブライザーやデジタル化製品の導入増加
    • スマート吸入器メーカーとソフトウェア企業によるデジタルヘルスパートナーシップ
  • 抑制要因
    • スマート吸入器の開発に伴う入手の制限と高コスト
  • 機会
    • スマート吸入器デバイスとシステムの技術的進歩
    • 市場参入企業による投資と研究開発の増加
  • 課題
    • 吸入器・ネブライザーに関連する実際的な問題
• 市場セグメンテーション分析
  • 製品：呼吸器疾患の負担を克服するための吸入器の幅広い入手可能性
  • 適応症：喘息治療における吸入器・ネブライザーに対する消費者の嗜好の増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ
  • 特許分析と動向

第6章 吸入器・ネブライザー市場：製品別

• 吸入器
  • ドライパウダー吸入器
  • 定量吸入器
• ネブライザー
  • ジェットネブライザー
  • メッシュネブライザー
  • 超音波ネブライザー

第7章 吸入器・ネブライザー市場適応症別

• 喘息
• 慢性閉塞性肺疾患

第8章 吸入器・ネブライザー市場配信モード別

• 病院薬局
• オンライン薬局
• 小売薬局

第9章 南北アメリカの吸入器・ネブライザー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の吸入器・ネブライザー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの吸入器・ネブライザー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 1nhaler、持続可能な使い捨て吸入器の開発に250万米ドルを調達
  • ルパンユニット、ドイツで喘息患者向け吸入器を導入
  • シナジーライフサイエンスがポータブルネブライザー「Nebi」を発売

企業一覧

• AMIKO Digital Health
• United Therapeutics Corporation
• PARI GmbH
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline PLC
• H&T Presspart
• CHIESI Farmaceutici S.p.A.
• Omron Corporation
• AptarGroup, Inc.
• 3M Company
• ICONOVO AB
• Beximco Pharmaceuticals Ltd.
• Koninklijke Philips N.V.
• GF Health Products, Inc.
• Narang Medical Limited
• Mundipharma GmbH
• Dr Trust by Nureca Ltd.
• Sunovion Pharmaceuticals Inc.
• Novartis AG
• Cipla Limited
• Merck Group
• Vectura Group Ltd.
• Beurer GmbH
• Drive DeVilbiss International
• Sensirion AG

LIST OF FIGURES

• FIGURE 1. INHALERS & NEBULIZERS MARKET RESEARCH PROCESS
• FIGURE 2. INHALERS & NEBULIZERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INHALERS & NEBULIZERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INHALERS & NEBULIZERS MARKET DYNAMICS
• TABLE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 72. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 158. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 162. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 178. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 183. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
• TABLE 233. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 234. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023

The Inhalers & Nebulizers Market was valued at USD 9.30 billion in 2023, expected to reach USD 11.45 billion in 2024, and is projected to grow at a CAGR of 22.55%, to USD 38.63 billion by 2030.

The scope of the Inhalers & Nebulizers market encompasses devices designed to deliver medication directly to the lungs, crucial for managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. The necessity of these devices arises from the increased prevalence of respiratory ailments and the demand for efficient drug delivery mechanisms. Application areas include hospitals, clinics, and home care settings, with end-users ranging from pediatric to geriatric patients. Market growth is influenced by factors like technological advancements, increased awareness about respiratory disorders, and the rising incidence of lifestyle-related respiratory issues due to urban pollution. Opportunities for growth include innovations in smart inhaler technology that integrates digital health tracking, and expanded market presence in developing regions with escalating healthcare infrastructure improvements.

However, challenges such as stringent regulatory environments, high costs associated with advanced devices, and limited awareness in less developed regions can impede growth. Limitations also arise from device inconsistency and technique variability that may affect treatment efficacy. To overcome these obstacles, companies can focus on innovation in areas like lightweight, portable nebulizers, and the development of cost-effective inhalers with enhanced precision and patient-friendly interfaces. Emerging research avenues include personalized medicine approaches facilitated by smart inhalers that monitor patient adherence and provide feedback. Market players can leverage these insights to enhance product differentiation and gain a competitive edge. Strategic recommendations include investing in R&D to create adaptive technology tailored to diverse patient needs and establishing partnerships with healthcare providers for comprehensive service offerings. The market is dynamic and competitive, driven by simultaneous demand for traditional and novel solutions, with an emphasis on user-friendly, efficient designs catering to a broad spectrum of respiratory conditions. Hence, aligning product development with technological advancements and consumer preferences will be key to capturing the full potential of the inhalers and nebulizers market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhalers & Nebulizers Market

The Inhalers & Nebulizers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Prevalence of Respiratory Diseases Globally
  • Increasing Adoption of Nebulizers and Digitally-Improved Products
  • Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
• Market Restraints
  • Limited Availability and High Costs Associated with the Development of Smart Inhalers
• Market Opportunities
  • Technological Advancements in Smart Inhaler Devices and Systems
  • Growing Investment and R&D by Market Players
• Market Challenges
  • Practical Problems Associated with Inhalers & Nebulizers

Porter's Five Forces: A Strategic Tool for Navigating the Inhalers & Nebulizers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhalers & Nebulizers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhalers & Nebulizers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhalers & Nebulizers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhalers & Nebulizers Market

A detailed market share analysis in the Inhalers & Nebulizers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhalers & Nebulizers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhalers & Nebulizers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include AMIKO Digital Health, United Therapeutics Corporation, PARI GmbH, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, H&T Presspart, CHIESI Farmaceutici S.p.A., Omron Corporation, AptarGroup, Inc., 3M Company, ICONOVO AB, Beximco Pharmaceuticals Ltd., Koninklijke Philips N.V., GF Health Products, Inc., Narang Medical Limited, Mundipharma GmbH, Dr Trust by Nureca Ltd., Sunovion Pharmaceuticals Inc., Novartis AG, Cipla Limited, Merck Group, Vectura Group Ltd., Beurer GmbH, Drive DeVilbiss International, and Sensirion AG.

Market Segmentation & Coverage

This research report categorizes the Inhalers & Nebulizers Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Inhalers and Nebulizers. The Inhalers is further studied across Dry Powder Inhalers and Metered Dose Inhalers. The Nebulizers is further studied across Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer.
• Based on Indication, market is studied across Asthma and COPD.
• Based on Distribution Mode, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Respiratory Diseases Globally
    • 5.1.1.2. Increasing Adoption of Nebulizers and Digitally-Improved Products
    • 5.1.1.3. Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
  • 5.1.2. Restraints
    • 5.1.2.1. Limited Availability and High Costs Associated with the Development of Smart Inhalers
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancements in Smart Inhaler Devices and Systems
    • 5.1.3.2. Growing Investment and R&D by Market Players
  • 5.1.4. Challenges
    • 5.1.4.1. Practical Problems Associated with Inhalers & Nebulizers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Wide availability of inhalers to overcome the respiratory disease burden
  • 5.2.2. Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization
  • 5.5.1. Patent Analysis & Trend

6. Inhalers & Nebulizers Market, by Product

• 6.1. Introduction
• 6.2. Inhalers
  • 6.2.1. Dry Powder Inhalers
  • 6.2.2. Metered Dose Inhalers
• 6.3. Nebulizers
  • 6.3.1. Jet Nebulizer
  • 6.3.2. Mesh Nebulizer
  • 6.3.3. Ultrasonic Nebulizer

7. Inhalers & Nebulizers Market, by Indication

• 7.1. Introduction
• 7.2. Asthma
• 7.3. COPD

8. Inhalers & Nebulizers Market, by Distribution Mode

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Americas Inhalers & Nebulizers Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Inhalers & Nebulizers Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Inhalers & Nebulizers Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. 1nhaler Raises USD 2.5 Million for Sustainable Single-Use Inhaler
  • 12.3.2. Lupin Unit Introduces Inhaler for Asthma Patients in Germany
  • 12.3.3. Synergy Life Science Releases Nebi, a Portable Nebulizer

Companies Mentioned

• 1. AMIKO Digital Health
• 2. United Therapeutics Corporation
• 3. PARI GmbH
• 4. Teva Pharmaceutical Industries Ltd.
• 5. GlaxoSmithKline PLC
• 6. H&T Presspart
• 7. CHIESI Farmaceutici S.p.A.
• 8. Omron Corporation
• 9. AptarGroup, Inc.
• 10. 3M Company
• 11. ICONOVO AB
• 12. Beximco Pharmaceuticals Ltd.
• 13. Koninklijke Philips N.V.
• 14. GF Health Products, Inc.
• 15. Narang Medical Limited
• 16. Mundipharma GmbH
• 17. Dr Trust by Nureca Ltd.
• 18. Sunovion Pharmaceuticals Inc.
• 19. Novartis AG
• 20. Cipla Limited
• 21. Merck Group
• 22. Vectura Group Ltd.
• 23. Beurer GmbH
• 24. Drive DeVilbiss International
• 25. Sensirion AG